Cost-effectiveness of amiodarone in cardiac surgery

Expert Review of Pharmacoeconomics and Outcomes Research

Volumn 7, Issue 1, 2007, Pages 19-30

  Denevich, Svetlana ^a   Boci, Kreda ^a   Reddy, Prabashni ^a  

^a ABT ASSOCIATES   (United States)

Author keywords

Amiodarone; Atrial fibrillation; Cardiac surgery; Cost; Economics

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IBUTILIDE; MACROLIDE; METOPROLOL; PLACEBO; PROCAINAMIDE; PYRROLE DERIVATIVE; QUINOLONE DERIVATIVE; SOTALOL;

BRADYCARDIA; CARDIOVERSION; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY SURGERY; COST EFFECTIVENESS ANALYSIS; DRUG ANTAGONISM; DRUG COST; DRUG MECHANISM; DRUG SUBSTITUTION; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART PACING; HEART SURGERY; HEART VALVE SURGERY; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HOSPITALIZATION; HOSPITALIZATION COST; HUMAN; HYPOTENSION; INCIDENCE; LENGTH OF STAY; LIVER TOXICITY; LOADING DRUG DOSE; LUNG TOXICITY; META ANALYSIS; NAUSEA AND VOMITING; NEUROTOXICITY; PERIPHERAL NEUROPATHY; PHOTOSENSITIVITY; PREOPERATIVE TREATMENT; PROPHYLAXIS; PROTHROMBIN TIME; QT PROLONGATION; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK FACTOR; RISK REDUCTION; SURGICAL MORTALITY; SYSTEMATIC REVIEW; THYROID DISEASE; VISUAL IMPAIRMENT;

EID: 33847126602     PISSN: 14737167     EISSN: 17448379     Source Type: Journal    
DOI: 10.1586/14737167.7.1.19     Document Type: Review

References (51)

1. Hilleman DE, Hunter CB, Mohiuddin SM, Maciejewski S. Pharmacological management of atrial fibrillation following cardiac surgery. Am. J. Cardiovasc. Drugs 5, 361-369 (2005).
2. Frost L, Molgaard H, Christiansen EH, Hjortholm K, Paulsen PK, Thomsen PE. Atrial fibrillation and flutter after coronary artery bypass surgery: epidemiology, risk factors and preventive trials. Int. J. Cardiol. 36, 253-261 (1992).
3. Falter JA, Adams GG, Buxton B. Atrial fibrillation after coronary artery bypass grafting. Is it a disorder of the elderly? J. Thorac. Cardiovasc. Surg. 97, 821-825 (1989).
4. Lauer MS, Eagle KA, Buckley MJ, DeSanctis RW. Atrial fibrillation following coronary artery bypass surgery. Prog. Cardiovasc. Dis. 31, 367-378 (1989).
5. Mathew JP, Parks R, Savino JS et al. Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes and resource utilization. MultiCenter Study of Perioperative Ischemia Research Group. JAMA 276, 300-306 (1996).
6. Ommen SR, Odell JA, Stanton MS. Atrial arrhythmias after cardiothoracic surgery. N. Engl. J. Med, 336, 1429-1434 (1997).
7. Page PL, Pym J. Atrial fibrillation following cardiac surgery. Can. J. Cardiol. 12 (Suppl. A), 40A-44A (1996).
8. Mathew J P Fontes ML, Tudor IC et al. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA 291, 1720-1729 (2004).
9. Taylor GJ, Malik SA, Colliver JA et al. Usefulness of atrial fibrillation as a predictor of stroke after isolated coronary artery bypass grafting. Am. J. Cardiol. 60, 905-907 (1987).
10. Rubin DA, Nieminski KE, Reed GE, Herman W. Predictors, prevention, and long-term prognosis of atrial fibrillation after coronary artery bypass graft operations. J. Thorac. Cardiovasc. Surg. 94, 331-335 (1987).
11. Ali IM, Sanalla AA, Clark V. β-blocker effects on postoperative atrial fibrillation. Eur J. Candiothorac. Surg. 11, 1154-1157 (1997).
12. Hashimoto K, Ilstrup DM, Schaff HV. Influence of clinical and hemodynamic variables on risk of supraventricular tachycardia after coronary artery bypass. J. Thorac. Candiovasc. Surg. 101, 56-65 (1991).
13. Silverman NA, Wright R, Levitsky S. Efficacy of low-dose propranolol in preventing postoperative supraventricular tachyarrhythmias: a prospective, randomized study. Ann. Surg. 196, 194-197 (1982).
14. Goldstein LB, Adams R, Becker K et al. Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation 103, 163-182 (2001).
15. Creswell LL, Schuessler RB, Rosenbloom M, Cox JL. Hazards of postoperative atrial arrhythmias. Ann. Thorac. Surg. 56, 539-549 (1993).
16. Aranki SF, Shaw DP, Adams DH et al. Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. Circulation 94, 390-397 (1996).
17. Fuster V, Ryden LE, Cannom DS et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J. Am. Coll. Cardiol. 48, e149-e246 (2006).
18. McKeown PP, Gutterman D. Executive summary: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest 128, S1-S5 (2005).
19. Crystal E, Garfinkle MS, Connolly SS, Ginger TT, Sleik K, Yusuf SS. Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery. Cochrane Database. Syst. Rev. CD003611 (2004).
20. Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. Am. J. Ophthalmol. 130, 688 (2000).
21. Concato J. Observational versus experimental studies: what's the evidence for a hierarchy? NeuroRx 1, 341-347 (2004).
22. Paccrone package insert. Upsher-Smith Laboratories, Inc, Minneapolis, MN, USA (2006).
23. Redbook. Pharmacy's Fundamental Reference. Medical Economics Thompson Healthcare, Montvale, NJ, USA, 218 (2005).
24. Gillespie EL, Coleman CI, Sander S, Kluger J, Gryskiewicz KA, White CM. Effect of prophylactic amiodarone on clinical and economic outcomes after cardiothoracic surgery: a meta-analysis. Ann. Pharmacother. 39, 1409-1415 (2005).
25. Zimmer J, Pezzullo J, Choucair W et al. Meta-analysis of antiarrhythmic therapy in the prevention of postoperative atrial fibrillation and the effect on hospital length of stay, costs, cerebrovascular accidents, and mortality in patients undergoing cardiac surgery. Am. J. Cardiol. 91, 1137-1140 (2003).
26. Bagshaw SM, Galbraith PD, Mitchell LB, Sauve R. Exner DV, Ghali WA. Prophylactic amiodarone fbr prevention of atrial fibrillation after cardiac surgery: a meta-analysis. Ann. Thorac. Surg. 82, 1927-1937 (2006).
27. Daoud EG, Strickberger SA, Man KC et al. Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. N. Engl. J. Med. 337, 1785-1791 (1997).
28. Giri S, White CM, Dunn AB et al. Oral amiodarone for prevention of atrial fibrillation after open heart surgery, the Atrial Fibrillation Suppression Trial (AFIST): a randomised placebo-controlled trial. Lancet 357, 830-836 (2001).
29. Guarnieri T, Nolan S, Gottlieb SO, Dudek A, Lowry DR. Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: the Amiodarone Reduction in Coronary Heart (ARCH) trial. J. Am. Coll. Cardiol, 34, 343-347 (1999).
30. Lee SH, Chang CM, Lu MJ et al. Intravenous amiodarone for prevention of atrial fibrillation after coronary artery bypass grafting. Ann. Thorac. Surg. 70, 157-161 (2000).
31. Redle JD, Khurana S, Marzan R et al. Prophylactic oral amiodarone compared with placebo for prevention of atrial fibrillation after coronary artery bypass surgery. Am. Heart. J. 138, 144-150 (1999).
32. White CM, Caron MF, Kalus JS et al. Intravenous plus oral amiodarone, atrial septal pacing, or both strategies to prevent post-cardiothoracic surgery atrial fibrillation: the Atrial Fibrillation Suppression Trial II (AFIST II). Circulation 108 (Suppl 1), II200-II206 (1999)
33. Reddy P, Kalus JS, Caron MF et al. Economic analysis of intravenous plus oral amiodarone, atrial septal pacing, and both strategies to prevent atrial fibrillation after open heart surgery. Pharmacotherapy 24, 1013-1019 (2004).
34. Kerstein J, Soodan A, Qamar M et al. Giving IV and oral amiodarone perioperatively for the prevention of postoperative atrial fibrillation in patients undergoing coronary artery bypass surgery: the GAP study. Chest 126, 716-724 (2004).
35. Kim MH, Rachwal W, McHale et al. Effect of amiodarone ± diltiazem ± β blocker on frequency of atrial fibrillation, length of hospitalization, and hospital costs after coronary artery bypass grafting. Am. J. Cardiol. 89, 1126-1128 (2002).
36. Barnes BJ, Kirkland EA, Howard PA et al. Risk-stratified evaluation of amiodarone to prevent atrial fibrillation after cardiac surgery. Ann. Thorac. Surg. 82, 1332-1337 (2006).
37. Gillespie EL, White CM, Kluger J, Rancourt JA, Gallagher R, Coleman CI. Cost-effectiveness of amiodarone for prophylaxis of atrial fibrillation after cardiothoracic surgery. Pharmacotherapy 26, 499-504 (2006).
38. Perkerson EA, Gillespie EL, White CM et al. Impact of prophylactic amiodarone on length of hospital stay, stroke, and atrial fibrillation after cardiothoracic surgery. Pharmacotherapy 25, 320-324 (2005).
39. Reddy P, Richerson M, Freeman-Bosco L, Dunn A, White CM, Chow MS. Cost-effectiveness of amiodarone for prophylaxis of atrial fibrillation in coronary artery bypass surgery. Am. J. Health. Syst. Pharm. 56, 2211-2217 (1999).
40. Reddy P, Gao X, Burrell A, Boci K, Bouin O. Cost-effectiveness of amiodarone to prevent atrial fibrillation after cardiac surgery. 10th ISPOR Annual International Meeting. Washington DC, USA, PCV 9 (2005).
41. Aasbo JD, Lawrence AT, Krishnan K, Kim MH, Trohman RG. Amiodarone prophylaxis reduces major cardiovascular morbidity and length of stay after cardiac surgery: a meta-analysis. Ann. Intern. Med. 143, 327-336 (2005).
42. Burgess DC, Kilborn MJ, Keech AC. Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis. Eur. Heart. J. 27, 2846-2857 (2006).
43. Auer J, Weber T, Berent R et al. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SPPAF), a randomized, placebo-controlled trial. Am. Heart. J. 147, 636-643 (2004).
44. Maras D, Boskovic SD, Popovic Z et al. Single-day loading dose of oral amiodarone for the prevention of new-onset atrial fibrillation after coronary artery bypass surgery. Am. Heart. J. 141, E8 (2001).
45. Mitchell LB, Exner DV, Wyse DG et al. Prophylactic Oral Amiodarone for the Prevention of Arrhythmias that Begin Early After Revascularization, Valve Replacement, or Repair: PAPABEAR: a randomized controlled trial. JAMA. 294, 3093-3100 (2005).
46. Solomon AJ, Greenberg MD, Kilborn MJ, Katz NM. Amiodarone versus a β-blocker to prevent atrial fibrillation after cardiovascular surgery. Am. Heart J. 142, 811-815 (2001).
47. Yagdi T, Nalbantgil S, Ayik F et al. Amiodarone reduces the incidence of atrial fibrillation after coronary artery bypass grafting. J. Thorac. Cardiovasc. Surg. 125, 1420-1425 (2003).
48. Mahoney EM, Thompson TD, Veledar E, Williams J, Weintraub WS. Cost-effectiveness of targeting patients undergoing cardiac surgery for therapy with intravenous amiodarone to prevent atrial fibrillation. J. Am. Coll Cardiol. 40, 737-745 (2002).
49. Weber UK Osswald S, Huber M et al. Selective versus non-selective antiarrhythmic approach for prevention of atrial fibrillation after coronary surgery: is there a need for pre-operative risk stratification? A prospective placebo-controlled study using low-dose sotalol. Eur Heart. J. 19, 794-800 (1998).
50. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-Effectiveness in Health and Medicine. Gold MR (Ed.), Weinstein MC (Ed.). Oxford University Press, New York, NY, USA (1996).
51. Dorge H, Schoendube FA, Schoberer M, Stellbrink C, Voss M, Messmer BJ. Intraoperative amiodarone as prophylaxis against atrial fibrillation after coronary operations. Ann. Thorac. Surg. 69, 1358-1362 (2000).